Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
調查:僅5%過敏患者打針後現不良反應 過敏者可安心打針

調查:僅5%過敏患者打針後現不良反應 過敏者可安心打針

Ta Kung Pao
Monday, March 28, 2022 09:32:07 AM UTC

  該協會向180名過敏患者發放調查問卷,以了解他們疫苗接種情況及疫苗安全性,參加者年齡介乎5至17歲,逾三分之二的患有濕疹,三分之一患有過敏性鼻炎,五分之一有食物過敏史,而其他受訪者有哮喘、藥物過敏和過敏性休克的過敏史。

  調查指,近九成受訪者已經接種至少一劑疫苗,約有55%受訪者已經接種兩劑疫苗,約34%已接種第三劑疫苗。調查亦指,有三分之二的受訪者願意在必要時接種加強劑。香港過敏協會表示,新冠疫苗對於過敏患者而言是極為安全的,即使有過敏病史的人士不應避免接種疫苗。

Read full story on Ta Kung Pao
Share this story on:-
More Related News
© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us